Skip to Content

OT-730 Approval Status

FDA Approved: No
Brand name: OT-730
Company: Othera Pharmaceuticals, Inc.
Treatment for: Glaucoma

OT-730 is an oculoselective beta-blocker under review as a potential treatment for glaucoma.

Development Status and FDA Approval Process for OT-730

DateArticle
Aug  7, 2008Othera Files IND Application for OT-730 in Glaucoma

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide